Mediator kinase inhibition reverses castration resistance of advanced prostate cancer-Reference-Cited by-同舟云学术

Mediator kinase inhibition reverses castration resistance of advanced prostate cancer

Published:2024-03-28 Issue:10 Volume:134 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Li Jing,Hilimire Thomas A.,Liu Yueying,Wang Lili,Liang Jiaxin^ORCID,Gyorffy Balazs,Sikirzhytski Vitali,Ji Hao,Zhang Li,Cheng Chen,Ding Xiaokai,Kerr Kendall R.,Dowling Charles E.,Chumanevich Alexander A.,Mack Zachary T.,Schools Gary P.,Lim Chang-uk,Ellis Leigh,Zi Xiaolin,Porter Donald C.,Broude Eugenia V.,McInnes Campbell,Wilding George,Lilly Michael B.,Roninson Igor B.,Chen Mengqian

Funder

National Cancer Institute

National Institute of General Medical Sciences

U.S. Department of Defense

Publisher

American Society for Clinical Investigation

Link

https://www.jci.org/articles/view/176709/files/pdf

Reference69 articles.

1. Cancer statistics, 2023

2. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer

3. Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity

4. Non-genetic mechanisms of therapeutic resistance in cancer

5. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer;Endocrinology;2024-08-27

2. Special Issue “Novel Chemical Tools for Targeted Cancer Therapy”;International Journal of Molecular Sciences;2024-05-30